Ochsner Health and BioInfoExperts Complete First Genomic Sequences of COVID-19 From New Orleans
Scientists from UF Innovate | Sid Martin Biotech startup BioInfoExperts LLC (BIE), a company that provides connected services and technologies related to detecting and monitoring pathogens in communities and the health care industry, and Ochsner Health, have completed the first whole-genome sequences of the SARS-CoV-2 coronavirus from the New Orleans area. By breaking down the virus to its most […]
Sid Martin Startup Alchem Awarded $20.7M for Clinical Trials on Potential COVID-19 Therapies
President Trump has pledged to release billions in funding to fight the coronavirus. Now, information from the Federal Procurement Data System shows well over $3.02 billion has been spent to date, almost half of which has come out of the Health and Human Services (HHS) department. UF Innovate | Sid Martin Biotech startup Alchem Laboratories […]
UF Startup TearClear Appoints Robert J. Dempsey as CEO
UF startup TearClear, a global Ophthalmic Pharmaceutical Company, announced the appointment of Robert J. Dempsey as Chief Executive Officer. TearClear, a resident client at UF Innovate | Sid Martin Biotech, is the only pharmaceutical company to administer preservative-free eye drops to the ocular surface, that are preserved safely prior to dosing. Dempsey, who has more […]
DiaCarta Gets FDA Emergency Use Authorization for Coronavirus PCR Test
UF Innovate | Sid Martin Biotech alum DiaCarta, a molecular diagnostic firm, has obtained the Emergency Use Authorization from the US Food and Drug Administration for its QuantiVirus PCR diagnostic (Dx) test for the novel coronavirus. The test detects the N, Orf1ab, and E genes of the SARS-CoV-2 virus in nasopharyngeal swabs, oropharyngeal swabs, and […]
From Chill to Kill – Pheronym Treated Nematodes Aggressively Disperse in Lower Temperatures
UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an ag-biotech pest control company, announced the results of their third peer-reviewed study demonstrating the efficacy of their patented Nematism pheromone extract for bio-remediation of agricultural pests. In a study to be published in Scientific Reports by Springer Nature, Dr. David […]
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., a company developing DNA medicines for infectious diseases and cancer, announced that the Department of Defense (DOD) has awarded Ology Bioservices with a contract valued at $11.9 million to work with Inovio on […]
DiaCarta SARS-CoV-2 Test Kit Receives CE Mark
Molecular diagnostic firm and UF Innovate | Sid Martin Biotech alum DiaCarta said that its QuantiVirus SARS-CoV-2 test recently received the CE mark. The firm has also filed for Emergency Use Authorization of the test with the US Food and Drug Administration. The company’s qRT-PCR test detects viral RNA extracted from nasopharyngeal swabs, oropharyngeal swabs, […]
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
The Department of Defense (DOD) awarded a contract valued at $14 million with UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus. This work is supported by the Office […]
AGTC Announces Completion of Enrollment in All Adult Dose Groups of Its Ongoing Phase 1/2 Clinical Trials in Patients With Achromatopsia
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including […]
Business News: Alachua Business Expanding
UF Innovate | Sid Martin Biotech has been sharing some exciting news about the incubator and client company Alchem Laboratories Corporation. Alchem, a research organization focused on drug manufacturing and development, announced recently the expansion of its screening and critical trial capabilities in Alachua with a new building. The corporation will construct a 12,000-square-foot building […]